Sign In
Buy ARCT
$5.76
-0.160 (-2.70%)
At Close: Jul 31, 2026
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates
07:09pm, Monday, 08'th Nov 2021
Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of -46.43% and -90.87%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the s
Earnings Preview: Arcturus Therapeutics (ARCT) Q3 Earnings Expected to Decline
04:06pm, Monday, 01'st Nov 2021
Arcturus Therapeutics (ARCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arcturus Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on November 8, 2021
04:00pm, Monday, 25'th Oct 2021
SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company foc
Cathie Wood Just Bought Shares of This Vaccine Underdog. Should You?
06:00am, Friday, 15'th Oct 2021
The company disappointed last year, but things may be turning around.
After COVID-19, Could This Be the Next Billion-Dollar Vaccine Market?
06:00am, Monday, 04'th Oct 2021
Three healthcare giants are vying for the prize.
Arcturus Therapeutics Announces Meeting with President of Vietnam and CEO of Vingroup to Discuss Expansion of COVID-19 Vaccine Collaboration
04:01pm, Wednesday, 22'nd Sep 2021
SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics Announces Meeting with President of Vietnam and CEO of Vingroup to Discuss Expansion of COVID-19 Vaccine Collaboration
SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine
Arcturus Therapeutics Presents Specific Asian COVID-19 Opportunity
06:36am, Friday, 10'th Sep 2021
The company has a specific opportunity to be a vaccine supplier within Asia and to the world.
7 Busted Biotech Stocks Due for a Rebound
12:25pm, Wednesday, 08'th Sep 2021
Buying biotech stocks while they're down is rewarding once they post positive clinical results, setting the stage for a big rally. The post 7 Busted Biotech Stocks Due for a Rebound appeared first on
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
09:00am, Tuesday, 07'th Sep 2021
SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
Tuesday Afternoon Analyst Upgrades and Downgrades: SmileDirectClub, Squarespace, Victoria's Secret and More
12:56pm, Tuesday, 10'th Aug 2021
With the trading day more than halfway over, the broad markets were mixed yet again, but this came with a couple of record highs.
ARCT Stock Price Increases Over 35% Pre-Market: Why It Happened
05:42am, Tuesday, 10'th Aug 2021
The stock price of Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) increased by over 35% pre-market. This is why it happened.
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q2 2021 Results - Earnings Call Transcript
01:26am, Tuesday, 10'th Aug 2021
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q2 2021 Results - Earnings Call Transcript
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Lags Revenue Estimates
06:28pm, Monday, 09'th Aug 2021
Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of -4.02% and -27.10%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Previews: AMC, New Oriental Education and 3 Cathie Wood Picks
01:23pm, Friday, 06'th Aug 2021
More than a third of earnings reports released Friday morning failed to meet consensus estimates for profits, revenues or both.
